Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2019
September 04 2019 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming
presentations at the following investor conferences in September.
- Bradley Campbell, President and Chief Operating Officer, and
Jeff Castelli, Chief Portfolio Officer and Head of Gene Therapy,
will participate in a fireside chat at the Baird 2019 Global
Healthcare Conference in New York, NY on Thursday, September 5,
2019 at 9:40 a.m. ET.
- Daphne Quimi, Chief Financial Officer, will present at the
Janney Healthcare Conference in New York, NY on Tuesday, September
10, 2019 at 11:50 a.m. ET.
A live audio webcast of both presentations can
be accessed via the Investors section of the Amicus Therapeutics
corporate website at
http://ir.amicusrx.com/events-and-presentations, and will be
archived for 90 days.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow us on Twitter and
LinkedIn.
CONTACTS:
Investors/Media:Amicus
TherapeuticsSara Pellegrino, IRCVice President, Investor Relations
& Corporate CommunicationsIR@amicusrx.com(609) 662-5044
Media:Amicus TherapeuticsMarco
Winklermwinkler@amicusrx.com(609) 662-2798
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2023 to Apr 2024